These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 34410063

  • 1. Retrolental amyloidosis of the vitreous body (case study).
    Shaimova VA, Nosul YV, Kuchkildina SK, Kulikov AN, Maltsev DS, Shaimov TB, Shaimov RB, Golovneva ES, Kravchenko TG, Kholopova AY, Ermilov VV, Berdnikov RB.
    Vestn Oftalmol; 2021; 137(4):98-103. PubMed ID: 34410063
    [Abstract] [Full Text] [Related]

  • 2. [Evaluation of YAG-laser vitreolysis effectiveness based on quantitative characterization of vitreous floaters].
    Shaimova VA, Shaimov TB, Shaimov RB, Galin AY, Goloshchapova ZA, Ryzhkov PK, Fomin AV.
    Vestn Oftalmol; 2018; 134(1):56-62. PubMed ID: 29543200
    [Abstract] [Full Text] [Related]

  • 3. Novel OCT Application and Optimized YAG Laser Enable Visualization and Treatment of Mid- to Posterior Vitreous Floaters.
    Singh IP.
    Ophthalmic Surg Lasers Imaging Retina; 2018 Oct 01; 49(10):806-811. PubMed ID: 30395668
    [Abstract] [Full Text] [Related]

  • 4. LASER VITREOLYSIS IN PATIENTS WITH SYMPTOMATIC VITREOUS FLOATERS.
    Janeková A, Veith M, Fillová D, Janek M.
    Cesk Slov Oftalmol; 2022 Oct 01; 78(6):288-295. PubMed ID: 36543595
    [Abstract] [Full Text] [Related]

  • 5. YAG Laser Vitreolysis vs Sham YAG Vitreolysis for Symptomatic Vitreous Floaters: A Randomized Clinical Trial.
    Shah CP, Heier JS.
    JAMA Ophthalmol; 2017 Sep 01; 135(9):918-923. PubMed ID: 28727887
    [Abstract] [Full Text] [Related]

  • 6. Needle-shaped deposits on retinal surface in a case of ocular amyloidosis.
    Hattori T, Shimada H, Yuzawa M, Kinukawa N, Fukuda T, Yasuda N.
    Eur J Ophthalmol; 2008 Sep 01; 18(3):473-5. PubMed ID: 18465738
    [Abstract] [Full Text] [Related]

  • 7. Safety and Efficacy of YAG Laser Vitreolysis for the Treatment of Vitreous Floaters: An Overview.
    Katsanos A, Tsaldari N, Gorgoli K, Lalos F, Stefaniotou M, Asproudis I.
    Adv Ther; 2020 Apr 01; 37(4):1319-1327. PubMed ID: 32086749
    [Abstract] [Full Text] [Related]

  • 8. Assessment of Vitreous Structure and Visual Function after Neodymium:Yttrium-Aluminum-Garnet Laser Vitreolysis.
    Nguyen JH, Nguyen-Cuu J, Yu F, Yee KM, Mamou J, Silverman RH, Ketterling J, Sebag J.
    Ophthalmology; 2019 Nov 01; 126(11):1517-1526. PubMed ID: 31471088
    [Abstract] [Full Text] [Related]

  • 9. Pars plana vitrectomy in a case of amyloidosis of the vitreous.
    van Rens GH, Doubois HF, Winkelman JE.
    Doc Ophthalmol; 1985 Jan 31; 59(1):45-9. PubMed ID: 3987496
    [Abstract] [Full Text] [Related]

  • 10. Nd:YAG vitreolysis and pars plana vitrectomy: surgical treatment for vitreous floaters.
    Delaney YM, Oyinloye A, Benjamin L.
    Eye (Lond); 2002 Jan 31; 16(1):21-6. PubMed ID: 11913884
    [Abstract] [Full Text] [Related]

  • 11. Laser vitreolysis for symptomatic floaters is not yet ready for widespread adoption.
    Su D, Shah CP, Hsu J.
    Surv Ophthalmol; 2020 Jan 31; 65(5):589-591. PubMed ID: 32135173
    [Abstract] [Full Text] [Related]

  • 12. [Vitreous floaters].
    Schmitz-Valckenberg S, Brasse K, Hoerauf H.
    Ophthalmologe; 2020 May 31; 117(5):485-496. PubMed ID: 32291480
    [Abstract] [Full Text] [Related]

  • 13. Efficacy and safety of yttrium-aluminium garnet (YAG) laser vitreolysis for vitreous floaters.
    Luo J, An X, Kuang Y.
    J Int Med Res; 2018 Nov 31; 46(11):4465-4471. PubMed ID: 30200800
    [Abstract] [Full Text] [Related]

  • 14. Eligibility criteria for Nd-YAG laser treatment of highly symptomatic vitreous floaters.
    Vandorselaer T, Van De Velde F, Tassignon MJ.
    Bull Soc Belge Ophtalmol; 2001 Nov 31; (280):15-9. PubMed ID: 11486460
    [Abstract] [Full Text] [Related]

  • 15. Iatrogenic Vitreous Hemorrhage, Subretinal Hemorrhage, and Branch Retinal Vein Occlusion after YAG Laser Vitreolysis for Symptomatic Vitreous Floaters.
    Shields RA, Cheng OT, Wolfe JD.
    Ophthalmology; 2021 Apr 31; 128(4):616. PubMed ID: 33745529
    [No Abstract] [Full Text] [Related]

  • 16. Modern vitreolysis-YAG laser treatment now a real solution for the treatment of symptomatic floaters.
    Singh IP.
    Surv Ophthalmol; 2020 Apr 31; 65(5):581-588. PubMed ID: 32135174
    [Abstract] [Full Text] [Related]

  • 17. Efficacy and safety of early YAG laser vitreolysis for symptomatic vitreous floaters: the study protocol for a randomized clinical trial.
    Hangshuai Z, Yanhua J, Yao Z, Guangjin Z, Hongyan W, Fanlian C.
    Trials; 2024 Jan 13; 25(1):48. PubMed ID: 38218919
    [Abstract] [Full Text] [Related]

  • 18. To Treat or Not to Treat: Management Options for Symptomatic Vitreous Floaters.
    Broadhead GK, Hong T, Chang AA.
    Asia Pac J Ophthalmol (Phila); 2020 Jan 13; 9(2):96-103. PubMed ID: 32097127
    [Abstract] [Full Text] [Related]

  • 19. Apolipoprotein AI-Derived Vitreous Amyloidosis: An Elusive Diagnosis.
    Yepez JB, Murati FA, Petitto M, De Yepez J, Galue JM, Vinardell S, Mura M, Arevalo JF.
    Case Rep Ophthalmol; 2020 Jan 13; 11(2):287-292. PubMed ID: 32774294
    [Abstract] [Full Text] [Related]

  • 20. [YAG laser vitreolysis for treatment of symptomatic vitreous opacities].
    Brasse K, Schmitz-Valckenberg S, Jünemann A, Roider J, Hoerauf H.
    Ophthalmologe; 2019 Jan 13; 116(1):73-84. PubMed ID: 30203171
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.